EUVIMEDEUVIMED entdecken
Crossref

MIA and CD163 as promising diagnostic biomarkers in vascular dementia: A multi-method study combining WGCNA, machine learning with validation in animal models and clinical samples

Yun-Meng Chen, Ze Chang, Xiao Liang, Li-Na Miao, Xian-Su Chi, Hong-Xi Liu, Wei Shen, Yun-Ling Zhang

International Immunopharmacology · 2025

DOI: 10.1016/j.intimp.2025.115146 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2025. Verfasst von Yun-Meng Chen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Xiyuan Hospital of China Academy of Chinese Medical Sciences, Beijing 100091, China. Hauptthemen laut MEDLINE: Antigens, Differentiation, Myelomonocytic, Receptors, Cell Surface, Antigens, CD, Dementia, Vascular. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: National Natural Science Foundation of China, State Administration of Traditional Chinese Medicine of the People's Republic of China, China Academy of Chinese Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Vascular dementia (VaD), the second most common form of dementia, lacks reliable biomarkers for early diagnosis. Here, we integrated weighted gene co-expression network analysis (WGCNA) with machine learning to identify novel biomarkers and immune-metabolic pathways in VaD. Analysis of the GSE122063 dataset revealed 288 differentially expressed genes (DEGs), with four hub genes (MIA, CD163, OPALIN, SNX31) prioritized by LASSO regression and Random Forest. A nomogram model incorporating these genes achieved an AUC of 0.924, demonstrating high diagnostic accuracy. External validation (GSE186798) and experimental studies confirmed significant upregulation of MIA and CD163 in VaD patients and a 2VO rat model (P < 0.05), while SNX31 and OPALIN showed inconsistent significance. Mechanistically, MIA and CD163 correlated with macrophage polarization (M1/M2) and dysregulated oxidative phosphorylation pathways, suggesting their dual roles in neuroinflammation and metabolic reprogramming. Serum ELISA further validated elevated MIA (14.34 ± 6.32 vs. 5.23 ± 4.89 ng/mL) and CD163 (141.31 ± 71.27 vs. 58.09 ± 54.31 ng/mL) in VaD patients (P < 0.05). Our study not only establishes MIA and CD163 as robust diagnostic biomarkers but also highlights their potential as therapeutic targets for modulating immune-metabolic crosstalk in VaD pathogenesis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antigens, Differentiation, MyelomonocyticReceptors, Cell SurfaceAntigens, CDDementia, VascularAnimalsCD163 AntigenHumansMachine LearningBiomarkersRatsDisease Models, AnimalMaleGene Regulatory NetworksFemaleMacrophagesAged

Stichwörter der Autor:innen

BiomarkersFeature genesImmune cell infiltrationVascular dementiaWGCNA analysis

Substanzen

CD163 AntigenAntigens, Differentiation, MyelomonocyticReceptors, Cell SurfaceAntigens, CDBiomarkers

Autor:innen und Institutionen

  • Xiyuan Hospital of China Academy of Chinese Medical Sciences, Beijing 100091, China.
  • Xiyuan Hospital of China Academy of Chinese Medical Sciences, Beijing 100091, China. Electronic address: 676665709@qq.com.
  • Xiyuan Hospital of China Academy of Chinese Medical Sciences, Beijing 100091, China. Electronic address: yunlingzhang2004@126.com.

Förderung

  • National Natural Science Foundation of China
  • State Administration of Traditional Chinese Medicine of the People's Republic of China
  • China Academy of Chinese Medical Sciences
  • Ministry of Education of the People's Republic of China Cultivation Fund of the Key Scientific and Technical Innovation Project

Zitieren

APA

Chen, Y. M., Chang, Z., Liang, X., Miao, L. N., Chi, X. S., Liu, H. X., Shen, W., & Zhang, Y. L. (2025). MIA and CD163 as promising diagnostic biomarkers in vascular dementia: A multi-method study combining WGCNA, machine learning with validation in animal models and clinical samples. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2025.115146

Vancouver

Chen YM, Chang Z, Liang X, Miao LN, Chi XS, Liu HX, et al. MIA and CD163 as promising diagnostic biomarkers in vascular dementia: A multi-method study combining WGCNA, machine learning with validation in animal models and clinical samples. International Immunopharmacology. 2025. doi:10.1016/j.intimp.2025.115146

BibTeX
@article{Chen2025,
  author = {Chen, Yun-Meng and Chang, Ze and Liang, Xiao and Miao, Li-Na and Chi, Xian-Su and Liu, Hong-Xi and Shen, Wei and Zhang, Yun-Ling},
  title = {MIA and CD163 as promising diagnostic biomarkers in vascular dementia: A multi-method study combining WGCNA, machine learning with validation in animal models and clinical samples},
  journal = {International Immunopharmacology},
  year = {2025},
  doi = {10.1016/j.intimp.2025.115146}
}
Kostenlos starten →